YungShin Global Holding Past Earnings Performance
Past criteria checks 5/6
YungShin Global Holding has been growing earnings at an average annual rate of 4.6%, while the Pharmaceuticals industry saw earnings growing at 8.1% annually. Revenues have been declining at an average rate of 3.2% per year. YungShin Global Holding's return on equity is 11.9%, and it has net margins of 13.2%.
Key information
4.6%
Earnings growth rate
4.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 18.5% |
| Revenue growth rate | -3.2% |
| Return on equity | 11.9% |
| Net Margin | 13.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
YungShin Global Holding (TWSE:3705) Is Due To Pay A Dividend Of NT$2.30
Jun 20
YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
May 09YungShin Global Holding (TWSE:3705) Will Pay A Dividend Of NT$2.30
Apr 25YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
Apr 01With EPS Growth And More, YungShin Global Holding (TPE:3705) Is Interesting
Apr 05If You Had Bought YungShin Global Holding (TPE:3705) Stock A Year Ago, You Could Pocket A 10% Gain Today
Mar 16These 4 Measures Indicate That YungShin Global Holding (TPE:3705) Is Using Debt Reasonably Well
Feb 22Does YungShin Global Holding Corporation (TPE:3705) Have A Place In Your Dividend Portfolio?
Feb 05
YungShin Global Holding Corporation's (TPE:3705) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Here's Why I Think YungShin Global Holding (TPE:3705) Is An Interesting Stock
Dec 31If You Had Bought YungShin Global Holding (TPE:3705) Shares Three Years Ago You'd Have Earned 12% Returns
Dec 16YungShin Global Holding's (TPE:3705) Earnings Are Growing But Is There More To The Story?
Dec 01Revenue & Expenses Breakdown
How YungShin Global Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 7,821 | 1,029 | 1,798 | 345 |
| 30 Jun 24 | 7,437 | 1,053 | 1,770 | 331 |
| 31 Mar 24 | 7,154 | 922 | 1,744 | 314 |
| 31 Dec 23 | 7,028 | 827 | 1,718 | 330 |
| 30 Sep 23 | 6,861 | 703 | 1,680 | 347 |
| 30 Jun 23 | 6,765 | 716 | 1,650 | 328 |
| 31 Mar 23 | 7,029 | 787 | 1,841 | 350 |
| 31 Dec 22 | 7,312 | 839 | 2,037 | 347 |
| 30 Sep 22 | 7,617 | 963 | 2,247 | 353 |
| 30 Jun 22 | 8,017 | 882 | 2,437 | 386 |
| 31 Mar 22 | 7,981 | 796 | 2,409 | 392 |
| 31 Dec 21 | 7,805 | 737 | 2,370 | 395 |
| 30 Sep 21 | 7,938 | 721 | 2,351 | 424 |
| 30 Jun 21 | 7,857 | 721 | 2,325 | 423 |
| 31 Mar 21 | 7,879 | 703 | 2,329 | 415 |
| 31 Dec 20 | 8,085 | 792 | 2,310 | 411 |
| 30 Sep 20 | 8,146 | 839 | 2,344 | 401 |
| 30 Jun 20 | 8,259 | 800 | 2,440 | 411 |
| 31 Mar 20 | 8,383 | 836 | 2,485 | 408 |
| 31 Dec 19 | 8,192 | 749 | 2,518 | 398 |
| 30 Sep 19 | 8,012 | 678 | 2,478 | 416 |
| 30 Jun 19 | 7,826 | 727 | 2,377 | 401 |
| 31 Mar 19 | 7,559 | 700 | 2,298 | 380 |
| 31 Dec 18 | 7,514 | 702 | 2,262 | 371 |
| 30 Sep 18 | 7,223 | 642 | 2,203 | 334 |
| 30 Jun 18 | 7,061 | 561 | 2,079 | 309 |
| 31 Mar 18 | 6,823 | 516 | 1,942 | 344 |
| 31 Dec 17 | 6,623 | 514 | 1,832 | 352 |
| 30 Sep 17 | 6,418 | 507 | 1,736 | 321 |
| 30 Jun 17 | 6,271 | 505 | 1,715 | 327 |
| 31 Mar 17 | 6,298 | 683 | 1,728 | 312 |
| 31 Dec 16 | 6,191 | 658 | 1,731 | 322 |
| 30 Sep 16 | 6,174 | 862 | 1,688 | 329 |
| 30 Jun 16 | 6,076 | 983 | 1,659 | 331 |
| 31 Mar 16 | 6,031 | 838 | 1,618 | 301 |
| 31 Dec 15 | 6,034 | 893 | 1,564 | 301 |
| 30 Sep 15 | 5,981 | 745 | 1,506 | 376 |
| 30 Jun 15 | 5,968 | 719 | 1,485 | 370 |
| 31 Mar 15 | 5,926 | 736 | 1,478 | 393 |
| 31 Dec 14 | 5,827 | 720 | 1,468 | 379 |
| 30 Sep 14 | 5,706 | 763 | 1,467 | 305 |
| 30 Jun 14 | 5,555 | 707 | 1,430 | 319 |
| 31 Mar 14 | 5,267 | 658 | 1,381 | 341 |
| 31 Dec 13 | 5,062 | 619 | 1,344 | 348 |
Quality Earnings: 3705 has high quality earnings.
Growing Profit Margin: 3705's current net profit margins (13.2%) are higher than last year (10.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3705's earnings have grown by 4.6% per year over the past 5 years.
Accelerating Growth: 3705's earnings growth over the past year (46.3%) exceeds its 5-year average (4.6% per year).
Earnings vs Industry: 3705 earnings growth over the past year (46.3%) exceeded the Pharmaceuticals industry 11.9%.
Return on Equity
High ROE: 3705's Return on Equity (11.9%) is considered low.